Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 24

1.

Plant-derived 3,3'-Diindolylmethane is a strong androgen antagonist in human prostate cancer cells.

Le HT, Schaldach CM, Firestone GL, Bjeldanes LF.

J Biol Chem. 2003 Jun 6;278(23):21136-45. Epub 2003 Mar 27.

2.

The development of Casodex (bicalutamide): preclinical studies.

Furr BJ.

Eur Urol. 1996;29 Suppl 2:83-95. Review.

PMID:
8717469
3.

Androgens, androgen receptors, antiandrogens and the treatment of prostate cancer.

Griffiths K, Morton MS, Nicholson RI.

Eur Urol. 1997;32 Suppl 3:24-40. Review.

PMID:
9267783
4.

Antiandrogens: selective androgen receptor modulators.

Berrevoets CA, Umar A, Brinkmann AO.

Mol Cell Endocrinol. 2002 Dec 30;198(1-2):97-103. Review.

PMID:
12573819
5.

Indole-3-carbinol and prostate cancer.

Sarkar FH, Li Y.

J Nutr. 2004 Dec;134(12 Suppl):3493S-3498S. Review.

PMID:
15570059
6.

Hormonal effects on cell proliferation in rat prostate.

Bruchovsky N, Lesser B, Van Doorn E, Craven S.

Vitam Horm. 1975;33:61-102. Review.

PMID:
180681
7.

Casodex: preclinical studies and controversies.

Furr BJ.

Ann N Y Acad Sci. 1995 Jun 12;761:79-96. Review. No abstract available.

PMID:
7625752
8.

Replacement of surgical castration by GnRH inhibition for rat prostate androgen receptor preparations.

Ashby J, Lefevre PA.

J Appl Toxicol. 2001 Sep-Oct;21(5):353-4. Review. No abstract available.

PMID:
11746178
9.

Antiandrogen effects in models of androgen responsive cancer.

Shain SA, Huot RI.

J Steroid Biochem. 1988 Oct;31(4B):711-8. Review.

PMID:
3059063
10.

Multifunctional aspects of the action of indole-3-carbinol as an antitumor agent.

Bradlow HL, Sepkovic DW, Telang NT, Osborne MP.

Ann N Y Acad Sci. 1999;889:204-13. Review.

PMID:
10668495
11.

Androgen receptor assays in advanced prostatic cancer.

Buttyan R, Olsson CA.

Urol Clin North Am. 1984 May;11(2):311-7. Review.

PMID:
6375068
12.

Cancer chemotherapy with indole-3-carbinol, bis(3'-indolyl)methane and synthetic analogs.

Safe S, Papineni S, Chintharlapalli S.

Cancer Lett. 2008 Oct 8;269(2):326-38. doi: 10.1016/j.canlet.2008.04.021. Epub 2008 May 22. Review.

13.

Cellular and Molecular Mechanisms of 3,3'-Diindolylmethane in Gastrointestinal Cancer.

Kim SM.

Int J Mol Sci. 2016 Jul 19;17(7). pii: E1155. doi: 10.3390/ijms17071155. Review.

14.

Developments in nonsteroidal antiandrogens targeting the androgen receptor.

Liu B, Su L, Geng J, Liu J, Zhao G.

ChemMedChem. 2010 Oct 4;5(10):1651-61. doi: 10.1002/cmdc.201000259. Review. No abstract available.

PMID:
20853390
15.

Attenuation of multi-targeted proliferation-linked signaling by 3,3'-diindolylmethane (DIM): from bench to clinic.

Banerjee S, Kong D, Wang Z, Bao B, Hillman GG, Sarkar FH.

Mutat Res. 2011 Jul-Oct;728(1-2):47-66. doi: 10.1016/j.mrrev.2011.06.001. Epub 2011 Jun 15. Review.

16.
17.

Minireview: modulation of hormone receptor signaling by dietary anticancer indoles.

Firestone GL, Sundar SN.

Mol Endocrinol. 2009 Dec;23(12):1940-7. doi: 10.1210/me.2009-0149. Epub 2009 Oct 16. Review.

18.

Chemopreventive properties of indole-3-carbinol, diindolylmethane and other constituents of cardamom against carcinogenesis.

Acharya A, Das I, Singh S, Saha T.

Recent Pat Food Nutr Agric. 2010 Jun;2(2):166-77. Review.

PMID:
20653562
19.

[Indole derivatives in vegetables of the family Cruciferae].

Preobrazhenskaia MN, Korolev AM.

Bioorg Khim. 2000 Feb;26(2):97-111. Review. Russian.

PMID:
10808405
20.

Indole-3-Carbinol and Its Role in Chronic Diseases.

Licznerska B, Baer-Dubowska W.

Adv Exp Med Biol. 2016;928:131-154. Review.

PMID:
27671815

Supplemental Content

Support Center